The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Trans-cellular Propagation of Tau Aggregation by Fibrillar Species
Open accessAbstract
Aggregation of the microtubule associated protein Tau is associated with several neurodegenerative disorders, including Alzheimer disease and frontotemporal dementia. In Alzheimer disease, Tau pathology spreads progressively throughout the brain, possibly along existing neural networks. However, it is still unclear how the propagation of Tau misfolding occurs. Intriguingly, in animal models, vaccine-based therapies have reduced Tau and synuclein pathology by uncertain mechanisms, given that these proteins are intracellular. We have previously speculated that trans-cellular propagation of misfolding could be mediated by a process similar to prion pathogenesis, in which fibrillar Tau aggregates spread pathology from cell to cell. However, there has been little evidence to demonstrate true trans-cellular propagation of Tau misfolding, in which Tau aggregates from one cell directly contact Tau protein in the recipient cell to trigger further aggregation. Here we have observed that intracellular Tau fibrils are directly released into the medium and then taken up by co-cultured cells. Internalized Tau aggregates induce fibrillization of intracellular Tau in these naive recipient cells via direct protein-protein contact that we demonstrate using FRET. Tau aggregation can be amplified across several generations of cells. An anti-Tau monoclonal antibody blocks Tau aggregate propagation by trapping fibrils in the extracellular space and preventing their uptake. Thus, propagation of Tau protein misfolding among cells can be mediated by release and subsequent uptake of fibrils that directly contact native protein in recipient cells. These results support the model of aggregate propagation by templated conformational change and suggest a mechanism for vaccine-based therapies in neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In cell culture, C2N-8E12 prevented pathological tau seeding caused by exogenous tau aggregates212.”
From Tau-targeting therapies for Alzheimer disease (2018) · cites this paper as [212]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Neurodegenerative Diseases Target Large-Scale Human Brain Networks
Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.024 · Cited by 2,350
Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Transmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427
Cited by
Sorted by citations
Items 501–546 of 546
Lewis, P. A., & Spillane, J. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811069-0.00004-5
Mechanistic Insight into Tau Fibril Cross-Seeding Barriers: Structural Order and Disorder
Weismiller, H. A. (2019) · Digital Commons - DU (University of Denver)
The Analysis of Exosomal Tau Release and its Regulation
Bradshaw, A. (2018) · UCL Discovery (University College London)
Lazo, J. S. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718049966.793482227
Cappa, S. F. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735988257.793576095
Lemon, R. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718173761.793557138
Makwana, K. M., Sarnowski, M. P., Miao, J., Lin, Y., & Valle, J. R. D. (2021) · ChemRxiv · doi:10.26434/chemrxiv.14478225
Analysis of Adult Hippocampal Neurogenesis in Neurodegenerative disease
HAN, G. (2022) · Cronfa (Swansea University) · doi:10.23889/suthesis.62147
An efficient method to generate fluorescent amyloid fibrilsPreprint
Prajapati, K. P., Ansari, M., Yadav, D. K., Anand, B. G., Mittal, S., & Kar, K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.28.522083
Neuron-specific resilience to proteostatic stress
Wolzak, K. (2023) · doi:10.5463/thesis.349
Gerdes, C., & Basmanav, F. B. (2024) · Plasmid · doi:10.1016/j.plasmid.2024.102729
del Rı́o, J. A., Lidón, L., & Gavı́n, R. (2025) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-97055-9_6
Benin, B. M., Hillyer, T., Csubak, B. A., Aguirre, N., Crish, S. D., Kang, C., & Shin, W. S. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100449
Gibbons, G. S., Kim, S.-J., Wu, Q., Riddle, D. M., Leight, S. N., Changolkar, L. N., Xu, H., Meymand, E. S., O’Reilly, M., Zhang, B., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13192098
de Thé, F.-X. B., Lassus, B., Schaler, A. W., Fowler, S. L., Goulbourne, C. N., Jeggo, R., Mannoury la Cour, C., Millan, M. J., & Duff, K. (2021) · Figshare · doi:10.6084/m9.figshare.16921850
Jin, N., 顾建兰, Wu, R., Chu, D., Tung, Y. C., Węgiel, J., Wisniewski, T., Gong, C.-X., Iqbal, K., & Liu, F. (2022) · Figshare · doi:10.6084/m9.figshare.20968215
Gibbons, G. S., Kim, S.-J., Wu, Q., Riddle, D. M., Leight, S. N., Changolkar, L. N., Xu, H., Meymand, E. S., O’Reilly, M., Zhang, B., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13192104
Gibbons, G. S., Kim, S.-J., Wu, Q., Riddle, D. M., Leight, S. N., Changolkar, L. N., Xu, H., Meymand, E. S., O’Reilly, M., Zhang, B., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13192095
Additional file 1 of Synaptic tau: A pathological or physiological phenomenon?
Robbins, M., Clayton, E. L., & Schierle, G. S. K. (2021) · Figshare · doi:10.6084/m9.figshare.16599510
Gibbons, G. S., Kim, S.-J., Wu, Q., Riddle, D. M., Leight, S. N., Changolkar, L. N., Xu, H., Meymand, E. S., O’Reilly, M., Zhang, B., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13192101
Ding, X., Xiang, Z., Qin, C., Chen, Y., Tian, H., Meng, L., Xia, D., Liu, H., Song, J., Fu, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13605566
Penny, L. K., Arastoo, M., Lofthouse, R. A., Abdallah, A., Imoesi, P. I., Schwab, K., Shiells, H., Melis, V., Riedel, G., Harrington, C. R., et al. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-01985-x
Sepulveda-Diaz, J. E. (2013) · theses.fr (ABES) · doi:10.70675/56c42bcbz41dfz432bzbb78z77110b373285
Les nanotubes comme nouvelle voie de transfert et de propagation de la protéine Tau pathologique
Tardivel, M. (2017) · theses.fr (ABES) · doi:10.70675/0cfcd049z970ez4f2dz8417z195cfabdc00d
Development of Inhibitors of Amyloid Fibril Propagation
Bendifallah, M. (2019) · theses.fr (ABES) · doi:10.70675/a872e5bdzc153z41f4z9472z725fd78aab48
Study of the Neuron-Astrocyte Relationship in a Rodent Model of Tauopathy
de Gérando, A. M. (2019) · theses.fr (ABES) · doi:10.70675/04658671zaca3z4fefza24dz2f5a011bebfe
Caractérisations biochimiques des protéines à répétitions de dipeptides et de leurs assemblages
Brasseur, L. (2019) · theses.fr (ABES) · doi:10.70675/9c659bfdz83dez45e5za549z64f5d270b2f9
Caractérisation d'anticorps à domaine unique dirigés contre la protéine Tau
Danis, C. (2018) · theses.fr (ABES) · doi:10.70675/c783a062zb57bz4024z85d0z509baaed8a1b
Altered neuronal activity in the hippocampal CA3 region in an in vitro model of tauopathy
Goncalves, A. (2020) · theses.fr (ABES) · doi:10.70675/b42db6dez88a0z4a14z93eez8f51d19d46f5
New insights into tau protein with regard to Alzheimer’s disease and other tauopathies
Billah, M. M., Hossin, A., Nawrin, K., & Ahmed, F. (2021) · Pharmacotherapy and Pharmascience Discovery · doi:10.66944/ptherpscid/ppd2183
Mostowfi, N., Foreman, R. P., Wang, J., Khoury, R., Albanese, A., Ma, Q. L., Cohn, W., Petzinger, G. M., Jakowec, M. W., Ahmed, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.09.731185
Huang, P., Jiang, S., Chen, Z., Liu, N., Li, H., Wang, A., Luo, L., Huang, W., Chen, S., & Deng, Y. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.07.003
The Tau-mitochondria connection and its impact on cellular energy metabolism in Alzheimer’s disease
Singh, A. K., Supraja, M. R., Amal, P. S., Krishnamoorthi, S., Iyaswamy, A., & Durairajan, S. S. K. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.06.002
Contribution of G4 Structure to Alzheimer’s Disease and Tau Pathology
Kallweit, L. M. (2026) · Digital Commons - DU (University of Denver) · doi:10.56902/etdcrp.2026.63
When Pathologies Collide: The Intersection of Tau and Alpha-Synuclein in Neurodegenerative Diseases
Hunt, J. N., & Kortagere, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06163-6
Prions: To What Units of Heredity Do They Belong?
Tikhodeyev, O. N. (2026) · Cell and Tissue Biology · doi:10.1134/s1990519x26600638
Metadata
- Authors
- Kfoury, N., Holmes, B. B., Jiang, H., Holtzman, D. M., & Diamond, M. I.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Diamond, Marc I.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 287
- Issue
- 23
- Pages
- 19440-19451
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC3365982
- OpenAlex
- W2032355167
- Cited by
- 552
- References
- 43
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 18 · 2023: 29 · 2022: 34 · 2021: 51 · 2020: 47 · 2019: 59 · 2018: 48 · 2017: 46 · 2016: 41 · 2015: 41 · 2014: 47 · 2013: 43 · 2012: 15
- FWCI
- 31.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Health Assistance Foundation
- Ruth K. Broad Biomedical Research Foundation
- Muscular Dystrophy Association
- Washington University in St. Louis
- Foundation for Barnes-Jewish Hospital
- Alvin J. Siteman Cancer Center
- Hope Center for Neurological Disorders
- National Institutes of Health (NS057105)
- Tau Consortium
- Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. Louis
- National Institute on Aging (P50AG005681)
- National Institute of Neurological Disorders and Stroke (F31NS079039, P30NS057105, NS057105, R01NS071835)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau aggregation, Alzheimer's disease, frontotemporal dementia, protein misfolding, prion-like propagation, protein-protein contacts, neurodegenerative diseases
- MeSH terms
- Alzheimer Disease, Humans, Models, Biological, tau Proteins, Protein Folding, Multiprotein Complexes, Antibodies, Neutralizing, Frontotemporal Dementia, HEK293 Cells, Antibodies, Monoclonal, Murine-Derived
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
